NASDAQ:MLAB - Nasdaq - US59064R1095 - Common Stock - Currency: USD
141.7
-4.2 (-2.88%)
The current stock price of MLAB is 141.7 USD. In the past month the price decreased by -0.5%. In the past year, price increased by 35.29%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 24.36 | 203.70B | ||
DHR | DANAHER CORP | 28.07 | 151.18B | ||
A | AGILENT TECHNOLOGIES INC | 25.59 | 38.62B | ||
IQV | IQVIA HOLDINGS INC | 17.15 | 33.64B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 31.26 | 26.91B | ||
WAT | WATERS CORP | 31.58 | 22.26B | ||
ICLR | ICON PLC | 14.39 | 16.63B | ||
WST | WEST PHARMACEUTICAL SERVICES | 31.25 | 15.27B | ||
ILMN | ILLUMINA INC | 38.45 | 14.94B | ||
RVTY | REVVITY INC | 23.23 | 13.85B | ||
AVTR | AVANTOR INC | 17.3 | 11.78B | ||
TEM | TEMPUS AI INC | N/A | 10.72B |
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 736 full-time employees. Its segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. The company also provides testing and laboratory services, mainly to the dental and pharmaceutical industries. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services quality control products. The company has manufacturing operations in the United States and Europe.
MESA LABORATORIES INC
12100 W 6th Ave
Lakewood COLORADO 80228 US
CEO: Gary M. Owens
Employees: 736
Company Website: https://mesalabs.com
Investor Relations: https://investors.mesalabs.com
Phone: 13039878000
The current stock price of MLAB is 141.7 USD. The price decreased by -2.88% in the last trading session.
The exchange symbol of MESA LABORATORIES INC is MLAB and it is listed on the Nasdaq exchange.
MLAB stock is listed on the Nasdaq exchange.
10 analysts have analysed MLAB and the average price target is 136 USD. This implies a price decrease of -4.02% is expected in the next year compared to the current price of 141.7. Check the MESA LABORATORIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MESA LABORATORIES INC (MLAB) has a market capitalization of 769.43M USD. This makes MLAB a Small Cap stock.
MESA LABORATORIES INC (MLAB) currently has 736 employees.
MESA LABORATORIES INC (MLAB) has a support level at 131.04 and a resistance level at 146.98. Check the full technical report for a detailed analysis of MLAB support and resistance levels.
The Revenue of MESA LABORATORIES INC (MLAB) is expected to grow by 12.09% in the next year. Check the estimates tab for more information on the MLAB EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MESA LABORATORIES INC (MLAB) has a dividend yield of 0.44%. The yearly dividend amount is currently 0.64. Check the full fundamental report for a detailed analysis of MLAB dividend history, reliability and sustainability.
MESA LABORATORIES INC (MLAB) will report earnings on 2025-05-29, after the market close.
The PE ratio for MESA LABORATORIES INC (MLAB) is 27.89. This is based on the reported non-GAAP earnings per share of 5.08 and the current share price of 141.7 USD. Check the full fundamental report for a full analysis of the valuation metrics for MLAB.
The outstanding short interest for MESA LABORATORIES INC (MLAB) is 3.62% of its float. Check the ownership tab for more information on the MLAB short interest.
ChartMill assigns a technical rating of 8 / 10 to MLAB. When comparing the yearly performance of all stocks, MLAB is one of the better performing stocks in the market, outperforming 91.03% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to MLAB. There are concerns on the financial health of MLAB while its profitability can be described as average.
Over the last trailing twelve months MLAB reported a non-GAAP Earnings per Share(EPS) of 5.08. The EPS increased by 2888.24% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -57.06% | ||
ROE | -160.71% | ||
Debt/Equity | 0.61 |
ChartMill assigns a Buy % Consensus number of 78% to MLAB. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 73.21% and a revenue growth 12.09% for MLAB